Suraksha Diagnostics Pvt Limited introduced Next Generation Sequencing (NGS) Technology on clinical diagnostics for the first time in Eastern India.
The press conference was graced by the presence of Dr Diptendra Kumar Sarkar, Ritu Mittal, Dr Somnath Chatterjee, Dr Anupama Gaur and Dr Tridip Chatterjee.
The technology uses parallel DNA or RNA sequencing enabling deep sequencing for mutation detection. This is the medical science of future and will be an essential tool for personalized medicine.
In its inception, comprehensive hotspot panel, breast cancer screening and comprehensive panel (BRCA1, BRCA2), non-invasive prenatal screening, pre-implantation genetic screening and specific gene panel for cardiovascular diseases can be screened.
Connect with us on Facebook at: https://www.facebook.com/sholoanabangaliana?ref=hl
Our You Tube Channel: https://www.youtube.com/channel/UC2nKhJo7Qd_riZIKxRO_RoA
Our Twitter Handle: @Sholoana1
Google+ ID: +Sholoana